MarketCapExport financials
MEDIROM Healthcare Technologies (MRM)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
MEDIROM Healthcare Technologies Balance Sheet 2024-2011 | MRM
Brief overview of MEDIROM Healthcare Technologies 's assets and capital
The review uses the five latest available annual reports between 2018 and 2024.
Assets advanced +78.9% to 8.1 billion JPY from 4.5 billion JPY; annual growth near 10.2% reflects a fast increase in scale.
Liabilities grew more slowly than assets: +48.8% versus +78.9%. Expansion relied more on equity, improving funding quality.
Equity covers only 11.5% of assets versus initially. The loss-absorbing cushion is limited.
The net-debt-to-equity ratio is 1.32x. Borrowed funding is already a meaningful part of the structure.
By the end of the period, accumulated earnings were 229 million JPY; the change from the start was +131.7%.
Balance sheet takeaway
MEDIROM Healthcare Technologies 's financial structure is not clear-cut. Asset scale alone does not resolve questions about how those assets are funded.
Annual Balance Sheet MEDIROM Healthcare Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.23 B | 1.71 B | - | - | 645 M | 8.48 M | 545 M | - | - | - | - | - | - | - |
Long Term Debt |
764 M | 1.05 B | - | - | 668 M | 151 M | 343 M | - | - | - | - | - | - | - |
Long Term Debt Current |
793 M | 763 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 1.17 B | 1.89 B | 2.29 B | - | - | - | - | - | - | - |
Total Current Liabilities |
4.18 B | 3.56 B | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.9 B | 6.63 B | - | - | 2.66 B | 4.16 B | 4.64 B | - | - | - | - | - | - | - |
Deferred Revenue |
53.5 M | 109 M | - | - | 442 M | 483 M | 522 M | - | - | - | - | - | - | - |
Retained Earnings |
229 M | 80.3 M | - | - | -2.1 B | -705 M | -723 M | - | - | - | - | - | - | - |
Total Assets |
8.09 B | 6.85 B | 6.75 B | - | 3.04 B | 4.76 B | 4.52 B | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
329 M | 106 M | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
1.19 B | 216 M | 6.75 B | - | 380 M | 600 M | -118 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
933 M | 211 M | -59.4 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in JPY currency
Quarterly Balance Sheet MEDIROM Healthcare Technologies
| 2025-Q2 | 2024-Q4 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
720 M | 764 M | 1.05 B | - | - | - | - | 747 M | - | - | - | 668 M | - | - | - | 151 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
7.5 B | 6.9 B | 6.63 B | - | - | - | - | 5.96 B | - | - | - | 5.22 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
21 M | 53.5 M | 109 M | - | - | - | - | 104 M | - | - | - | 172 M | - | - | - | 202 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-461 M | 229 M | 80.3 M | - | - | - | - | -2.69 B | - | - | - | -1.7 B | - | - | - | -705 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
8 B | 8.09 B | 6.85 B | 6.75 B | - | - | - | 5.75 B | - | - | - | 5.71 B | - | - | - | 4.76 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
32.7 M | 329 M | 106 M | - | - | - | - | 371 M | - | - | - | 1.44 B | - | - | - | 514 M | - | - | - | 212 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
498 M | 1.19 B | 216 M | 6.75 B | - | - | - | -208 M | - | - | - | 491 M | - | - | - | 4.76 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
243 M | 933 M | 211 M | -59.4 M | - | - | - | -208 M | - | - | - | 491 M | - | - | - | 600 M | - | - | - | -118 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in JPY currency
Balance Sheet is a fundamental financial report of MEDIROM Healthcare Technologies , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Personal services
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Carriage Services
CSV
|
$ 31.72 | 0.14 % | $ 489 M |  USA |
 |
frontdoor
FTDR
|
$ 73.95 | 0.87 % | $ 5.41 B | USA |
 |
H&R Block
HRB
|
$ 42.54 | 0.07 % | $ 5.43 B | USA |
 |
Regis Corporation
RGS
|
$ 27.55 | 2.04 % | $ 69.4 M | USA |
 |
Rollins
ROL
|
$ 32.49 | 1.58 % | $ 15.7 B | USA |
 |
Service Corporation International
SCI
|
$ 77.85 | 0.05 % | $ 11 B | USA |
 |
WW International
WW
|
$ 15.03 | 0.31 % | $ 150 M | USA |
 |
Franchise Group
FRG
|
- | - | $ 1.17 B | USA |
 |
Terminix Global Holdings
TMX
|
- | - | $ 4.6 B | USA |
 |
Bright Horizons Family Solutions
BFAM
|
$ 66.51 | 2.37 % | $ 3.79 B | USA |
 |
Medifast
MED
|
$ 11.95 | 0.41 % | $ 131 M | USA |
 |
StoneMor
STON
|
- | 0.57 % | $ 419 M | USA |